<article article-type="article" specific-use="production" xml:lang="en" xmlns:hw="org.highwire.hpp" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:ref="http://schema.highwire.org/Reference" xmlns:hwp="http://schema.highwire.org/Journal" xmlns:l="http://schema.highwire.org/Linking" xmlns:r="http://schema.highwire.org/Revision" xmlns:x="http://www.w3.org/1999/xhtml" xmlns:app="http://www.w3.org/2007/app" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nlm="http://schema.highwire.org/NLM/Journal" xmlns:a="http://www.w3.org/2005/Atom" xmlns:c="http://schema.highwire.org/Compound" xmlns:hpp="http://schema.highwire.org/Publishing"><front><journal-meta><journal-id journal-id-type="hwp">biorxiv</journal-id><journal-id journal-id-type="publisher-id">BIORXIV</journal-id><journal-title>bioRxiv</journal-title><abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title><publisher><publisher-name>Cold Spring Harbor Laboratory</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1101/432419</article-id><article-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;432419v1</article-id><article-id pub-id-type="other" hwp:sub-type="pisa-master">biorxiv;432419</article-id><article-id pub-id-type="other" hwp:sub-type="slug">432419</article-id><article-id pub-id-type="other" hwp:sub-type="tag">432419</article-id><article-version>1.1</article-version><article-categories><subj-group subj-group-type="author-type"><subject>Regular Article</subject></subj-group><subj-group subj-group-type="heading"><subject>New Results</subject></subj-group><subj-group subj-group-type="hwp-journal-coll" hwp:journal-coll-id="Neuroscience" hwp:journal="biorxiv"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title hwp:id="article-title-1">Venlafaxine stimulates PNN proteolysis and MMP-9 dependent enhancement of gamma power; relevance to antidepressant efficacy</article-title></title-group><author-notes hwp:id="author-notes-1"><fn id="n1" fn-type="equal" hwp:id="fn-1" hwp:rev-id="xref-fn-1-1 xref-fn-1-2"><label>*</label><p hwp:id="p-1">These authors contributed equally</p></fn><corresp id="cor1" hwp:id="corresp-1" hwp:rev-id="xref-corresp-1-1"><label>#</label>To whom correspondence should be addressed: <email hwp:id="email-1">kec84@georgetown.edu</email>, 202 687 8614 (tel), 202 687 0617 (fax)</corresp></author-notes><contrib-group hwp:id="contrib-group-1"><contrib contrib-type="author" hwp:id="contrib-1"><name name-style="western" hwp:sortable="S. Alaiyed"><surname>S.</surname><given-names>Alaiyed</given-names></name><degrees>M.S./M.D.</degrees><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-1" hwp:rel-id="aff-1">1</xref></contrib><contrib contrib-type="author" hwp:id="contrib-2"><name name-style="western" hwp:sortable="P. L. Bozzelli"><surname>P. L.</surname><given-names>Bozzelli</given-names></name><degrees>M.A.</degrees><xref ref-type="fn" rid="n1" hwp:id="xref-fn-1-1" hwp:rel-id="fn-1">*</xref><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-1" hwp:rel-id="aff-2">2</xref><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-1" hwp:rel-id="aff-3">3</xref></contrib><contrib contrib-type="author" hwp:id="contrib-3"><name name-style="western" hwp:sortable="A. Caccavano"><surname>A.</surname><given-names>Caccavano</given-names></name><degrees>M.S.</degrees><xref ref-type="fn" rid="n1" hwp:id="xref-fn-1-2" hwp:rel-id="fn-1">*</xref><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-2" hwp:rel-id="aff-1">1</xref><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-2" hwp:rel-id="aff-3">3</xref></contrib><contrib contrib-type="author" hwp:id="contrib-4"><name name-style="western" hwp:sortable="J.Y. Wu"><surname>J.Y.</surname><given-names>Wu</given-names></name><degrees>Ph.D.</degrees><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-2" hwp:rel-id="aff-2">2</xref><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-3" hwp:rel-id="aff-3">3</xref></contrib><contrib contrib-type="author" corresp="yes" hwp:id="contrib-5"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-3882-9810</contrib-id><name name-style="western" hwp:sortable="K. Conant"><surname>K.</surname><given-names>Conant</given-names></name><degrees>M.D.</degrees><xref ref-type="corresp" rid="cor1" hwp:id="xref-corresp-1-1" hwp:rel-id="corresp-1">#</xref><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-3" hwp:rel-id="aff-2">2</xref><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-4" hwp:rel-id="aff-3">3</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0003-3882-9810"/></contrib><aff id="a1" hwp:id="aff-1" hwp:rev-id="xref-aff-1-1 xref-aff-1-2"><label>1</label><institution hwp:id="institution-1">Departments of Pharmacology Georgetown University Medical Center</institution>, 3970 Reservoir Road, Washington, D.C. 20007; <country>U.S.A.</country></aff><aff id="a2" hwp:id="aff-2" hwp:rev-id="xref-aff-2-1 xref-aff-2-2 xref-aff-2-3"><label>2</label><institution hwp:id="institution-2">Departments of Neuroscience Georgetown University Medical Center</institution>, 3970 Reservoir Road, Washington, D.C. 20007; <country>U.S.A.</country></aff><aff id="a3" hwp:id="aff-3" hwp:rev-id="xref-aff-3-1 xref-aff-3-2 xref-aff-3-3 xref-aff-3-4"><label>3</label><institution hwp:id="institution-3">Departments of Interdisciplinary Program in Neuroscience Georgetown University Medical Center</institution>, 3970 Reservoir Road, Washington, D.C. 20007; <country>U.S.A.</country></aff></contrib-group><pub-date pub-type="epub-original" hwp:start="2018"><year>2018</year></pub-date><pub-date pub-type="hwp-created" hwp:start="2018-10-01T17:27:09-07:00">
    <day>1</day><month>10</month><year>2018</year>
  </pub-date><pub-date pub-type="hwp-received" hwp:start="2018-10-01T17:27:09-07:00">
    <day>1</day><month>10</month><year>2018</year>
  </pub-date><pub-date pub-type="epub" hwp:start="2018-10-01T17:33:58-07:00">
    <day>1</day><month>10</month><year>2018</year>
  </pub-date><pub-date pub-type="epub-version" hwp:start="2018-10-01T17:33:58-07:00">
    <day>1</day><month>10</month><year>2018</year>
  </pub-date><elocation-id>432419</elocation-id><history hwp:id="history-1">
<date date-type="received" hwp:start="2018-10-01"><day>01</day><month>10</month><year>2018</year></date>
<date date-type="rev-recd" hwp:start="2018-10-01"><day>01</day><month>10</month><year>2018</year></date>
<date date-type="accepted" hwp:start="2018-10-01"><day>01</day><month>10</month><year>2018</year></date>
</history><permissions><copyright-statement hwp:id="copyright-statement-1">© 2018, Posted by Cold Spring Harbor Laboratory</copyright-statement><copyright-year>2018</copyright-year><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/" hwp:id="license-1"><p hwp:id="p-2">This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at <ext-link l:rel="related" l:ref-type="uri" l:ref="http://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/" hwp:id="ext-link-1">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link></p></license></permissions><self-uri xlink:href="432419.pdf" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/abstract" xlink:role="abstract" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:href="file:/content/biorxiv/vol0/issue2019/pdf/432419v1.pdf" hwp:variant="yes" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:role="full-text" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/source" xlink:role="source" content-type="xml" xlink:show="none" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/original" xlink:role="original" content-type="xml" xlink:show="none" hwp:variant="yes" xlink:href="432419.xml"/><self-uri content-type="abstract" xlink:href="file:/content/biorxiv/vol0/issue2019/abstracts/432419v1/432419v1.htslp"/><self-uri content-type="fulltext" xlink:href="file:/content/biorxiv/vol0/issue2019/fulltext/432419v1/432419v1.htslp"/><abstract hwp:id="abstract-1"><title hwp:id="title-1">Abstract</title><p hwp:id="p-3">Drugs that target monoaminergic transmission represent a first-line treatment for major depression. Though a full understanding of the mechanisms that underlie antidepressant efficacy is lacking, evidence supports a role for enhanced excitatory transmission. This can occur through two non-mutually exclusive mechanisms. The first involves increased function of excitatory neurons through relatively direct mechanisms such as enhanced dendritic arborization. Another mechanism involves reduced inhibitory function, which occurs with the rapid antidepressant ketamine. Consistent with this, GABAergic interneuron-mediated cortical inhibition is linked to reduced gamma oscillatory power, a rhythm also diminished in depression. Remission of depressive symptoms correlates with restoration of gamma power.</p><p hwp:id="p-4">Due to strong excitatory input, reliable GABA release and fast firing, PV neurons represent critical pacemakers for synchronous oscillations. PV neurons also represent the predominant GABAergic population enveloped by perineuronal nets (PNNs), lattice-like structures that localize glutamatergic input. Disruption of PNNs enhances lateral diffusion of glutamate receptors, reduces PV excitability, and enhances gamma activity.</p><p hwp:id="p-5">Studies suggest that monoamine reuptake inhibitors reduce integrity of the PNN. Mechanisms by which these inhibitors reduce PNN integrity, however, remain largely unexplored. A better understanding of these issues might encourage development of therapeutics that best upregulate PNN modulating proteases.</p><p hwp:id="p-6">We observe that the serotonin/norepinephrine reuptake inhibitor venlafaxine reduces PNN integrity in murine brain. Moreover, venlafaxine treated mice (30 mg/kg/day) show an increase in carbachol-induced gamma power in hippocampal slices. Studies with mice deficient in matrix metalloproteinase-9 (MMP-9), a protease linked to PNN disruption in other settings, suggest that MMP-9 contributes to venlafaxine-enhanced gamma activity.</p></abstract><counts><page-count count="23"/></counts></article-meta></front><body><sec id="s1" hwp:id="sec-1"><title hwp:id="title-2">Introduction</title><p hwp:id="p-7">Major depressive disorder (MDD) is a debilitating condition that affects ∼12–17% of individuals in the U.S.at some point during their lifetime. This places a substantial burden on those affected and on family and friends. Moreover, untreated depression may increase one’s risk for substance abuse and Alzheimer’s disease (<xref ref-type="bibr" rid="c1" hwp:id="xref-ref-1-1" hwp:rel-id="ref-1">1</xref>, <xref ref-type="bibr" rid="c2" hwp:id="xref-ref-2-1" hwp:rel-id="ref-2">2</xref>).</p><p hwp:id="p-8">While a full understanding of molecular underpinnings is lacking, studies suggest that depression is linked to reductions in the strength of glutamatergic synaptic subsets in regions including hippocampus and prefrontal cortex (PFC). Animal models have shown changes including reduced GluA1 expression in layer V pyramidal cells, and impaired hippocampal long-term potentiation (LTP) [reviewed in (<xref ref-type="bibr" rid="c3" hwp:id="xref-ref-3-1" hwp:rel-id="ref-3">3</xref>)].</p><p hwp:id="p-9">In terms of effective treatment, one mechanism by which antidepressants may enhance glutamatergic transmission involves generation of new glutamatergic synapses. Animal models support this as successful treatment has been linked to an increase in the number of dendritic spines, which represent post-synaptic processes for the majority of excitatory synapses in the central nervous system (<xref ref-type="bibr" rid="c4" hwp:id="xref-ref-4-1" hwp:rel-id="ref-4">4</xref>). Enhanced dendritic spine number could potentially follow from antidepressant-mediated increases in neurotrophins.</p><p hwp:id="p-10">A non-mutually exclusive mechanism by which primary or adjunct therapeutics could improve glutamatergic signaling is through reduced inhibition of glutamatergic neurons. This possibility is supported by the rapid antidepressant activity of ketamine, which can stimulate disinhibition by acting as a preferential antagonist for GluNs localized to inhibitory interneurons (<xref ref-type="bibr" rid="c3" hwp:id="xref-ref-3-2" hwp:rel-id="ref-3">3</xref>). Importantly, new research has shown that negative allosteric modulation of the α5 GABA-A receptor subunit increases electroencephalographic gamma power (<xref ref-type="bibr" rid="c5" hwp:id="xref-ref-5-1" hwp:rel-id="ref-5">5</xref>), a rhythm that is reduced in human depression and an animal model of depression, and also normalized with remission (<xref ref-type="bibr" rid="c6" hwp:id="xref-ref-6-1" hwp:rel-id="ref-6">6</xref>, <xref ref-type="bibr" rid="c7" hwp:id="xref-ref-7-1" hwp:rel-id="ref-7">7</xref>). The same allosteric modulator concomitantly improves performance in the forced swim test (<xref ref-type="bibr" rid="c5" hwp:id="xref-ref-5-2" hwp:rel-id="ref-5">5</xref>).</p><p hwp:id="p-11">An alternative means to affect cortical disinhibition is through manipulation of the perineuronal net (PNN), a lattice like extracellular matrix that is predominantly localized to parvalbumin (PV) expressing interneurons (<xref ref-type="bibr" rid="c8" hwp:id="xref-ref-8-1" hwp:rel-id="ref-8">8</xref>, <xref ref-type="bibr" rid="c9" hwp:id="xref-ref-9-1" hwp:rel-id="ref-9">9</xref>). The PNN facilitates properly localized glutamatergic input to PV cells (<xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-1" hwp:rel-id="ref-10">10</xref>), thus enhancing PV mediated inhibition. Disruption of the PNN leads to increased lateral diffusion of glutamate receptor subunits on PV cells (<xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-2" hwp:rel-id="ref-10">10</xref>), and it may also result in increased diffusion of glutamate. Consistent with this, enzymatic degradation of the PNN reduces the frequency of excitatory post synaptic currents in hippocampal fast spiking interneurons (<xref ref-type="bibr" rid="c11" hwp:id="xref-ref-11-1" hwp:rel-id="ref-11">11</xref>). Recent work also suggests that PNN disruption can enhance cortical excitation and gamma activity (<xref ref-type="bibr" rid="c12" hwp:id="xref-ref-12-1" hwp:rel-id="ref-12">12</xref>).</p><p hwp:id="p-12">In terms of antidepressant therapy and the PNN, it is of interest that chronic treatment with fluoxetine decreases PNN staining in murine medial PFC and hippocampus (<xref ref-type="bibr" rid="c13" hwp:id="xref-ref-13-1" hwp:rel-id="ref-13">13</xref>). Recently published work has also shown that a stress related model of depression increases PNN staining (<xref ref-type="bibr" rid="c14" hwp:id="xref-ref-14-1" hwp:rel-id="ref-14">14</xref>).</p><p hwp:id="p-13">A relatively unexplored question is whether PNN reduction makes a substantial contribution to antidepressant efficacy and, if so, whether therapeutics or combinations beyond fluoxetine may best achieve this. The significance of this possibility is underlined by the widespread distribution of PNN enwrapped PV interneurons. As opposed to GABA-A α5 subunits, which have a depression-relevant but relatively restricted expression in forebrain, PNN enveloped PV neurons are found in multiple brain areas important to mood and memory.</p><p hwp:id="p-14">Studies that have examined PNN disruption for its potential to mediate cortical disinhibition have typically employed hyaluronidase, which targets the PNN backbone, or chondroitinase, which targets chrondroitan sulfate proteoglycan side chains. Physiologically relevant modulators of PNN integrity are, however, expressed in the central nervous system. Important among these modulators are proteases belonging to the metalloproteinase (MMP) family.</p><p hwp:id="p-15">MMP-9, MMP-13, and select transmembrane MMPs have been well linked to PNN component cleavage <italic toggle="yes">in vivo</italic> (<xref ref-type="bibr" rid="c15" hwp:id="xref-ref-15-1" hwp:rel-id="ref-15">15</xref>). For example, light reintroduction after dark exposure triggers MMP-9 dependent PNN degradation (<xref ref-type="bibr" rid="c16" hwp:id="xref-ref-16-1" hwp:rel-id="ref-16">16</xref>). In addition, seizure activity has been shown to increase MMP-9 levels and PNN breakdown while pretreatment with a broad-spectrum MMP inhibitor abrogates these effects (<xref ref-type="bibr" rid="c17" hwp:id="xref-ref-17-1" hwp:rel-id="ref-17">17</xref>). Further, in murine models of brain injury, selective MMP inhibition also reduces PNN remodeling (<xref ref-type="bibr" rid="c18" hwp:id="xref-ref-18-1" hwp:rel-id="ref-18">18</xref>).</p><p hwp:id="p-16">Of interest, PNN degrading MMPs may be upregulated by monoamines or reuptake inhibitors (<xref ref-type="bibr" rid="c19" hwp:id="xref-ref-19-1" hwp:rel-id="ref-19">19</xref>). Consistent with this possibility is work demonstrating increased MMP-9 expression in venlafaxine treated rats (<xref ref-type="bibr" rid="c20" hwp:id="xref-ref-20-1" hwp:rel-id="ref-20">20</xref>). While effects of specific monoamines on MMP release from brain-derived cells have not been extensively studied, in non-neural cells, norepinephrine has been shown to enhance MMP expression as well as MMP dependent endpoints (<xref ref-type="bibr" rid="c21" hwp:id="xref-ref-21-1" hwp:rel-id="ref-21">21</xref>).</p><p hwp:id="p-17">In the present study, we focus on the question of whether one of the most commonly prescribed antidepressants, venlafaxine, can stimulate PNN proteolysis and disinhibition as measured by its ability to upregulate carbachol-induced gamma power. Our studies focus on the hippocampus, a region increasingly implicated in depression (<xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-1" hwp:rel-id="ref-22">22</xref>). We also explore a role for MMP-9 in venlafaxine-stimulated disinhibition.</p></sec><sec id="s2" hwp:id="sec-2"><title hwp:id="title-3">Materials and Methods</title><sec id="s2a" hwp:id="sec-3"><title hwp:id="title-4">Chemicals and reagents</title><p hwp:id="p-18">Venlafaxine and carbamoylcholine chloride (carbachol) were purchased from Sigma Chemical (St. Louis, MO; catalogue numbers PHR1736 and C4382). Carbachol was maintained in frozen 50 mM aliquots and reconstituted in ACSF to a final concentration of 40 μM just prior to slice treatment.</p></sec><sec id="s2b" hwp:id="sec-4"><title hwp:id="title-5">Subjects and drug administration</title><p hwp:id="p-19">Both male and female C57BL/6J (Jackson Laboratory, #000664) or MMP-9 homozygous null mice (Jackson Laboratory, #007084) that have been backcrossed to C57BL/6J mice for at least five generations were used for experiments. Both mouse strains were bred in-house. At approximately 4 weeks of age, a time at which hippocampal PNN deposition is complete (<xref ref-type="bibr" rid="c18" hwp:id="xref-ref-18-2" hwp:rel-id="ref-18">18</xref>), mice were treated for 2 weeks with saline or saline containing 30 mg/kg venlafaxine. While lower doses act predominantly on serotonin reuptake, this is a dose that has been shown to reduce uptake of both serotonin and norepinephrine (<xref ref-type="bibr" rid="c23" hwp:id="xref-ref-23-1" hwp:rel-id="ref-23">23</xref>). Treatments were delivered in a total volume of 200 μl and administered daily by intraperitoneal injection. Experiments were performed in accordance with National Institutes of Health guidelines and an institutionally approved protocol.</p></sec><sec id="s2c" hwp:id="sec-5"><title hwp:id="title-6">Preparation of brain lysates and ELISA</title><p hwp:id="p-20">Following saline or venlafaxine treatment and euthanasia, hemi brains were dissected and hippocampi were extracted and lysed in RIPA buffer [50 □ mM Tris, pH 7.5, 150 □ mM NaCl, 0.1% SDS, 1% IGEPAL, and 1X protease and phosphatase cocktail (Thermo Scientific 1861281)]. Lysates were sonicated for 10 □ seconds, placed on ice for 20 □ minutes, and centrifuged for 15 □ minutes at 14,000 □ rpm in 4 □ °C. Lysate supernatants were saved for analysis. Pro MMP9 protein concentration in hippocampal lysates were measured by ELISA, performed according to the manufacturer’s protocol (Mouse Pro-MMP-9, R&amp;D systems P162135).</p></sec><sec id="s2d" hwp:id="sec-6"><title hwp:id="title-7">PNN staining and microscopy</title><p hwp:id="p-21">Following saline or venlafaxine treatment and euthanasia, hemi brains were fixed overnight in 4% PFA/sucrose at 4° C. Brains were then paraffin-embedded and sectioned at 15 microns. Sections were washed 2–3 times with 1X-PBS, permeabilized with 1X-PBS containing .1% Triton X-100, blocked with 10% normal goat serum, and incubated with anti-parvalbumin (1:500, Sigma, P3088) overnight at 4° C. Following subsequent washes and incubation with a fluorescent secondary antibody for PV immunostaining and fluorescein-labeled Wisteria floribunda lectin (WFA) (1:1000, Vector Laboratories, FL-1351) for 2 hours at room temperature, sections were washed three times with 1X-PBS, counterstained with DAPI and mounted with Hydromount (National Diagnostics, HS-106) and allowed to dry several days at 4° C prior to confocal imaging.</p></sec><sec id="s2e" hwp:id="sec-7"><title hwp:id="title-8">PV and PNN cell quantification</title><p hwp:id="p-22">Images were acquired using a Leica SP8 laser scanning confocal microscope with an oil immersion, 20X objective with .40 numerical aperture. Laser intensity, gain, and pinhole settings were kept constant for all samples. Images were taken through a z-plane (8.5 μm) within the center of the tissue section, containing 20 stacks (0.4 μm/stack) from the dorsal hippocampus. Quantification of PV numbers with and without an associated PNN cells were counted for each image that were acquired from regions of interest (ROI) using 5–8 mice per group, and 1–3 slides per mouse (total of 13–15 images/group). Due to regional differences in PNN intensity, comparable regions were blindly analyzed for each animal.</p></sec><sec id="s2f" hwp:id="sec-8"><title hwp:id="title-9">Slice preparation</title><p hwp:id="p-23">Following treatment with vehicle (saline) or venlafaxine mice were anaesthetized with deep isoflourane inhalation and then rapidly decapitated. The whole brain was subsequently removed and chilled in cold (0° C) sucrose-based cutting artificial cerebrospinal fluid (sACSF) containing (in mM) 252 sucrose; 3 KCL; 2 CaCl2; 2 MgSO<sub>4</sub>;1.25 NaH2PO4; 26 NaHCO3; 10 dextrose and bubbled by 95% O<sub>2</sub>, 5% CO<sub>2</sub>. Hippocampal slices (480 um thick unless otherwise indicated) were cut in horizontal sections from dorsal to ventral brain with a vibratome (Leica, VT1000S). Horizontal sections were then bisected and right and left sided sections randomly placed to reduce potential confounds due to hemispheric differences. In addition, dorsal and ventral most slices were excluded due to potential PNN density differences along this axis. ACSF contained (in mM) NaCl, 132; KCl, 3; CaCl2, 2; MgSO4, 2; NaH2PO4, 1.25; NaHCO3, 26; dextrose 10; and saturated with 95% O2, 5% CO2 at 26° C. Slices were incubated for at least 120 minutes before being moved to the recording chamber.</p></sec><sec id="s2g" hwp:id="sec-9"><title hwp:id="title-10">Local field potential (LFP) recordings</title><p hwp:id="p-24">Low resistance glass microelectrodes (approximately 150K tip resistance) were used for LFP recordings of gamma frequency oscillations. Electrodes were filled with 1M NaCl in 1% agar, which prevents leakage of the electrode solution that could potentially alter conditions at the recording site. The recordings were done in a submerged chamber, and slices were perfused on both sides at a high flow rate (20 ml /min). Recordings were performed in CA1 stratum oriens proximal to CA2. For exposure of slices to carbachol, infusion was switched from ACSF to ACSF containing carbachol at 40 μM. After 150 seconds, the next 315 seconds were used for analysis (see next section).</p></sec><sec id="s2h" hwp:id="sec-10"><title hwp:id="title-11">Local Field Potential (LFP) Analysis</title><p hwp:id="p-25">The LFP signal was analyzed in 315s blocks, beginning 150s after the onset of carbachol perfusion. 60Hz line noise and harmonics were notch-filtered in pClamp 11 for subsequent analysis with a custom MATLAB algorithm. A Gaussian FIR band-pass filter with corrected phase delay was applied between 1–1000Hz, after which additional band-pass filters were applied for theta (4–12Hz), low gamma (25–55Hz), and high gamma (65–85Hz) ranges. The power was computed by integrating the entire 315s band-pass filtered signals.</p></sec><sec id="s2i" hwp:id="sec-11"><title hwp:id="title-12">Statistical analysis</title><p hwp:id="p-26">Data was entered into a Graph Pad Prism program and statistical analysis performed using Student’s t-test for 2 group comparisons or ANOVA for comparisons of more than 2 groups. Significance was set at p&lt;/ = 0.05.</p></sec></sec><sec id="s3" hwp:id="sec-12"><title hwp:id="title-13">Results</title><sec id="s3a" hwp:id="sec-13"><label>I.</label><title hwp:id="title-14">MMP-9 protein levels are increased, and PNN immunoreactivity reduced, in venlafaxine treated mice</title><p hwp:id="p-27">Previous studies have linked increased expression of molecules including brain derived neurotrophic factor (BDNF) to monoamine reuptake inhibitor effects (<xref ref-type="bibr" rid="c24" hwp:id="xref-ref-24-1" hwp:rel-id="ref-24">24</xref>). This work does not, however, preclude a significant role for additional molecular effectors of antidepressant efficacy. Previously published data has shown that venlafaxine is linked to increased mRNA expression of MMP-9 in the rat brain (<xref ref-type="bibr" rid="c20" hwp:id="xref-ref-20-2" hwp:rel-id="ref-20">20</xref>). With respect to the potential to disrupt PV to pyramidal cell input, which would likely have a profound influence on widespread population activity, MMP-9 has also been shown to diminish PNN integrity (<xref ref-type="bibr" rid="c16" hwp:id="xref-ref-16-2" hwp:rel-id="ref-16">16</xref>, <xref ref-type="bibr" rid="c18" hwp:id="xref-ref-18-3" hwp:rel-id="ref-18">18</xref>). Since MMP-9 has been linked to reductions in PNN levels in the setting of both FXS (<xref ref-type="bibr" rid="c18" hwp:id="xref-ref-18-4" hwp:rel-id="ref-18">18</xref>) and light reintroduction following dark exposure (<xref ref-type="bibr" rid="c16" hwp:id="xref-ref-16-3" hwp:rel-id="ref-16">16</xref>), we examined PNN levels in control and venlafaxine treated mice.</p><p hwp:id="p-28">Hippocampal lysates were analyzed by ELISA for levels of MMP-9. As shown in <xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-1" hwp:rel-id="F1">figure 1A</xref>, venlafaxine treatment significantly increased hippocampal concentrations of this enzyme (n = 7–8; p = 0.0129; Student’s t-test). For results shown in <xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-2" hwp:rel-id="F1">figure 1B</xref>, hippocampal sections were stained for both PV and PNN immunoreactivity and the ratio of PV positive to PNN positive cells quantified. In venlafaxine treated animals, the ratio was significantly increased (n = 8; N = 13–14 <italic toggle="yes">p</italic> = 0.023; Student’s t-test). PV numbers were not increased (control 8.15 +/− 0.87; venlafaxine 7.93 +/− 0.85; p = 0.84), suggesting that PNN positivity was selectively reduced. Hippocampal PV and PNN staining for slice subsections are shown in <xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-3" hwp:rel-id="F1">figures 1C and D</xref>. The scale bar represents 75 μM and representative PNN enwrapped PV cells are indicated by arrows.</p><fig id="fig1" position="float" orientation="portrait" fig-type="figure" hwp:id="F1" hwp:rev-id="xref-fig-1-1 xref-fig-1-2 xref-fig-1-3"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;432419v1/FIG1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F1</object-id><object-id pub-id-type="publisher-id">fig1</object-id><label>I.</label><caption hwp:id="caption-1"><title hwp:id="title-15">MMP-9 levels and PNN immunoreactivity in hippocampi from venlafaxine treated mice</title><p hwp:id="p-29"><bold>1A</bold>) MMP-9 concentrations in brain lysates from 8 control and 7 venlafaxine (VFX) treated mice. Venlafaxine treatment significantly increased hippocampal concentrations of this enzyme (Control 149.4 +/− 9.9; VFX 253.8 +/− 37.3; p = 0.0129; Student’s t-test). <bold>2B</bold>) A quantitative analysis of PV/PNN ratios from control and venlafaxine treated animals (n = 8 animals and N = 13–14 slides for each group) revealed a statistically significant increase in the venlafaxine group (<italic toggle="yes">p</italic> = 0.023; Student’s t-test). PV numbers were not increased (control 8.15 +/− 0.87; venlafaxine 7.93 +/− 0.85; p = 0.84; not shown graphically), suggesting that PNN positivity was selectively reduced. <bold>2C</bold>) PV (red) and PNN (green) immunoreactivity in murine hippocampi in slices from a control and venlafaxine treated animal as indicated. The scale bar represents 75 μM and representative PNN enwrapped PV cells are indicated by arrows.</p></caption><graphic xlink:href="432419_fig1" position="float" orientation="portrait" hwp:id="graphic-1"/></fig></sec><sec id="s3b" hwp:id="sec-14"><label>II.</label><title hwp:id="title-16">Venlafaxine increases the power of carbachol-induced gamma activity in ex vivo hippocampal slices</title><p hwp:id="p-30">The hippocampus receives cholinergic input from the medial septum-diagonal band of Broca and this input is thought to be an important effector of physiological gamma (<xref ref-type="bibr" rid="c25" hwp:id="xref-ref-25-1" hwp:rel-id="ref-25">25</xref>). In isolated hippocampal slices, the cholinergic agonist carbachol is widely used to induce gamma (<xref ref-type="bibr" rid="c25" hwp:id="xref-ref-25-2" hwp:rel-id="ref-25">25</xref>). Because chondroitinase mediated PNN degradation has been linked to increased gamma in the visual cortex, and because alterations in gamma may be of relevance to the depressive phenotype (<xref ref-type="bibr" rid="c7" hwp:id="xref-ref-7-2" hwp:rel-id="ref-7">7</xref>), we examined the possibility that venlafaxine treatment could impact this rhythm. In <xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-1" hwp:rel-id="F2">figure 2A</xref> we show representative local field potential (LFP) recordings between treatments, as well as filtered signals in the theta (4–12Hz) and low and high gamma ranges (25–55 and 65–85Hz respectively). In <xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-2" hwp:rel-id="F2">figure 2B</xref> we show there is a statistically significant increase in low and high gamma power for the venlafaxine treated animals (<italic toggle="yes">p</italic> = 0.008 and 0.05 respectively; Student’s t-test; n = 4–6 animals and 1–2 slices per animal for each group). In <xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-3" hwp:rel-id="F2">figure 2C</xref>, we show the ratio of post- to pre- carbachol gamma power for each slice. This approach may partially address potential confounds introduced by differences in slice viability or electrode placement. Again we detect a significant difference between slices from wild type saline and venlafaxine treated animals in low gamma (p = 0.0246) and a tendency towards significance in high gamma (p = 0.084).</p><fig id="fig2" position="float" orientation="portrait" fig-type="figure" hwp:id="F2" hwp:rev-id="xref-fig-2-1 xref-fig-2-2 xref-fig-2-3 xref-fig-2-4 xref-fig-2-5 xref-fig-2-6 xref-fig-2-7"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;432419v1/FIG2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F2</object-id><object-id pub-id-type="publisher-id">fig2</object-id><label>II.</label><caption hwp:id="caption-2"><title hwp:id="title-17">Venlafaxine increases the power of carbachol-induced gamma activity in ex vivo hippocampal slices</title><p hwp:id="p-31"><bold>2A</bold>) Representative local field potential (LFP) recordings from slices obtained from a saline or venlafaxine treated animal. The LFP was filtered in the theta (4–8Hz), low and high gamma (25–55Hz and 65–85Hz respectively) ranges. <bold>2B</bold>) The average low and high gamma power of a 315s window beginning 150s after onset of carbachol perfusion was compared between treatment. For n = 4–6 animals, 1–2 slices per animal for each group, there is a statistically significant increase in low and high gamma power for the venlafaxine treated animals <italic toggle="yes">(p</italic> = 0.008 and 0.05 respectively; Student’s t test). <bold>2C</bold>), we show the ratio of post- to pre-carbachol gamma power for each slice. Again we detect a significant difference between slices from wild type saline and venlafaxine treated animals in low gamma (p = 0.0246) and a tendency towards significance in high gamma (p = 0.084).</p></caption><graphic xlink:href="432419_fig2" position="float" orientation="portrait" hwp:id="graphic-2"/></fig></sec><sec id="s3c" hwp:id="sec-15"><label>III.</label><title hwp:id="title-18">Venlafaxine stimulated changes in PNN integrity are reduced in MMP-9 null mice</title><p hwp:id="p-32">MMP-9 has been shown to reduce PNN integrity in mice that experience light reintroduction after deprivation, and also in a mouse model of FXS (<xref ref-type="bibr" rid="c16" hwp:id="xref-ref-16-4" hwp:rel-id="ref-16">16</xref>, <xref ref-type="bibr" rid="c18" hwp:id="xref-ref-18-5" hwp:rel-id="ref-18">18</xref>). MMP-9 may directly target PNN components or activate other proteases that do the same. To examine the possibility that this MMP-9 activity contributes to venlafaxine associated changes in the PNN, we treated MMP-9 null mice with saline or venlafaxine beginning at the same age and with the same dose and duration that had been utilized for wild type animals. Of note, previously published work has examined PNN deposition in wild type and MMP-9 knockout mice (<xref ref-type="bibr" rid="c18" hwp:id="xref-ref-18-6" hwp:rel-id="ref-18">18</xref>). Though knockouts showed reduced PV/PNN ratios (consistent with increased PNN) at P21, by P30 baseline PV/PNN levels were comparable between groups (<xref ref-type="bibr" rid="c18" hwp:id="xref-ref-18-7" hwp:rel-id="ref-18">18</xref>).</p><p hwp:id="p-33">Hippocampal PV and PNN staining for slice subsections are shown in <xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-1" hwp:rel-id="F3">figures 3A and B</xref>. PNN enwrapped PV cells are indicated by arrows, while a PV cell without an appreciable PNN is noted by the arrowhead. In 3C we show the PNN/PV ratio for both groups, with data from wild type mice again shown for comparison. There is no significant difference between control and venlafaxine treated MMP-9 null mice (1-way ANOVA; Tukey’s post hoc). In addition, the difference between control wild type and MMP-9 null mice is not significant (1-way ANOVA; Tukey’s post hoc). Interestingly however, there was a significant difference in the PNN/PV ratio in the control and venlafaxine treated MMP-9 null mice when these 2 groups were instead compared with Student’s t-test. The difference was reduced in magnitude as compared to the difference in wild type animals (1.6 fold increase in WT; 1.2 fold increase in MMP-9 null), but the persistence of differences in the MMP-9 null animals suggest that additional PNN degrading proteases may have been upregulated by venlafaxine.</p><fig id="fig3" position="float" orientation="portrait" fig-type="figure" hwp:id="F3" hwp:rev-id="xref-fig-3-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;432419v1/FIG3</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F3</object-id><object-id pub-id-type="publisher-id">fig3</object-id><label>III.</label><caption hwp:id="caption-3"><title hwp:id="title-19">Venlafaxine stimulated changes in PNN integrity are reduced in MMP-9 null mice</title><p hwp:id="p-34"><bold>3A-B</bold>) PNN and PV staining in slice subsections from treated and untreated MMP-9 null mice. Representative PNN enwrapped PV cells are indicated by arrows, while a PV cell without an appreciable PNN is noted by the arrowhead. Scale bar represents 75μM. <bold>3C</bold>) PNN/PV ratio for both groups, with data from wild type mice shown for comparison. There is no significant difference between control and venlafaxine treated MMP-9 null mice (1-way ANOVA; Tukey’s <italic toggle="yes">post hoc</italic>). As in wild type animals, the number of PV positive cells was not affected by venlafaxine (control 6.87 +/− 0.79, N = 14; venlafaxine 5.75 +/− 0.59, N = 16; p = 0.26). In addition, the difference between PV/PNN ratios in control wild type and MMP-9 null mice is not significant (1-way ANOVA; Tukey’s <italic toggle="yes">post hoc</italic>).</p></caption><graphic xlink:href="432419_fig3" position="float" orientation="portrait" hwp:id="graphic-3"/></fig></sec><sec id="s3d" hwp:id="sec-16"><label>IV.</label><title hwp:id="title-20">Venlafaxine does not significantly increase the power of carbachol-induced gamma activity in ex vivo hippocampal slices from MMP-9 knockout mice</title><p hwp:id="p-35">Given that venlafaxine stimulated a lesser fold reduction of PNN integrity in MMP-9 nulls as compared to wild type, we also examined carbachol-stimulated gamma in saline and venlafaxine animals on the MMP-9 null background. Previous studies have examined baseline neurotransmission in these animals and observed that this was not impaired (<xref ref-type="bibr" rid="c26" hwp:id="xref-ref-26-1" hwp:rel-id="ref-26">26</xref>). Similarly MMP-9 inhibitors have no effects on baseline properties of neurotransmission and spine size or morphology [reviewed in (<xref ref-type="bibr" rid="c27" hwp:id="xref-ref-27-1" hwp:rel-id="ref-27">27</xref>)].</p><p hwp:id="p-36">In <xref ref-type="fig" rid="fig4" hwp:id="xref-fig-4-1" hwp:rel-id="F4">figure 4A</xref> we show representative LFP recordings and filtered signals in the theta, low and high gamma ranges from slices obtained from saline or venlafaxine-treated MMP-9 knockout animals. In 4B we show that in MMP9 knockout mice, we observed no significant increase in low or high gamma power with venlafaxine treatment (Student’s t test). Wild type mouse results (<xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-4" hwp:rel-id="F2">Figure 2B</xref>) shown again for comparison. In <xref ref-type="fig" rid="fig4" hwp:id="xref-fig-4-2" hwp:rel-id="F4">figure 4C</xref> we show post to pre carbachol ratio data in slices from saline and venlafaxine treated mice, with wild type results (<xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-5" hwp:rel-id="F2">Figure 2C</xref>) shown again for comparison. The post to pre carbachol ratio in low or high gamma is not significantly different between control and treatment in MMP-9 null animals.</p><fig id="fig4" position="float" orientation="portrait" fig-type="figure" hwp:id="F4" hwp:rev-id="xref-fig-4-1 xref-fig-4-2"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;432419v1/FIG4</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F4</object-id><object-id pub-id-type="publisher-id">fig4</object-id><label>IV.</label><caption hwp:id="caption-4"><title hwp:id="title-21">Venlafaxine does not significantly increase the power of carbachol-induced gamma activity in ex vivo hippocampal slices from MMP-9 knockout mice</title><p hwp:id="p-37"><bold>4A</bold>) Representative LFP recordings and filtered data from slices obtained from saline or venlafaxine treated MMP-9 null animals. <bold>4B</bold>) Analyses of average low and high gamma power revealed no statistically significant increase due to venlafaxine treatment in MMP-9 null animals (Student’s t test). Wild type mouse results (<xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-6" hwp:rel-id="F2">Figure 2B</xref>) shown again for comparison. <bold>4C</bold>) Post- to pre-carbachol ratio in slices from saline and venlafaxine treated mice, with wild type results (<xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-7" hwp:rel-id="F2">Figure 2C</xref>) shown again for comparison. The post to pre carbachol ratio in low or high gamma is not significantly different between control and treatment in MMP-9 null animals.</p></caption><graphic xlink:href="432419_fig4" position="float" orientation="portrait" hwp:id="graphic-4"/></fig></sec><sec id="s3e" hwp:id="sec-17"><label>V.</label><title hwp:id="title-22">Schematic overview</title><p hwp:id="p-38">In <xref ref-type="fig" rid="fig5" hwp:id="xref-fig-5-1" hwp:rel-id="F5">figure 5</xref> we show a hypothetical overview by which venlafaxine can influence PNN integrity and gamma power. First, hippocampal levels of serotonin and norepinephrine are increased in the background of venlafaxine treatment. These monoamines interact with G protein coupled receptors expressed on neurons and glia. Gαs protein coupled monoamine receptors in particular, including 5HT7 and the β1 adrenergic receptor (ADRB1), have been linked to increased MMP-9 expression [(<xref ref-type="bibr" rid="c19" hwp:id="xref-ref-19-2" hwp:rel-id="ref-19">19</xref>), Alaiyed S. <italic toggle="yes">et al</italic>., unpublished observations]. Increased levels of MMP-9 can in turn target PNN components and/or activate additional proteases that do the same. Reduced PNN integrity, likely localized to regions where monoaminergic transmission typically occurs, can in turn disrupt PV mediated inhibition of pyramidal cell activity with consequent effects on gamma power.</p><fig id="fig5" position="float" orientation="portrait" fig-type="figure" hwp:id="F5" hwp:rev-id="xref-fig-5-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;432419v1/FIG5</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F5</object-id><object-id pub-id-type="publisher-id">fig5</object-id><label>V.</label><caption hwp:id="caption-5"><title hwp:id="title-23">Hypothetical Overview</title><p hwp:id="p-39">Hippocampal levels of serotonin and norepinephrine are increased in response to venlafaxine treatment (far left). These monoamines interact with G-protein coupled receptors expressed on neurons (purple) and non-neuronal cells such as microglia (green) to increase expression of MMP-9. Increased levels of MMP-9 can in turn target PNN components and/or activate additional metalloproteases (MPs) that also target PNN substrates. Reduced PNN integrity can in turn disrupt PV-mediated inhibition of pyramidal cell activity with consequent effects on gamma power.</p></caption><graphic xlink:href="432419_fig5" position="float" orientation="portrait" hwp:id="graphic-5"/></fig></sec></sec><sec id="s4" hwp:id="sec-18"><title hwp:id="title-24">Discussion</title><p hwp:id="p-40">In the present study, we find that chronic treatment of mice with the serotonin/norepinephrine reuptake inhibitor venlafaxine concomitantly increases PNN proteolysis and hippocampal gamma power. We further observe that venlafaxine enhanced gamma power is significantly reduced in mice that are deficient in MMP-9, a family member that is expressed in response to neuronal activity (<xref ref-type="bibr" rid="c28" hwp:id="xref-ref-28-1" hwp:rel-id="ref-28">28</xref>) and monoamine exposure (<xref ref-type="bibr" rid="c19" hwp:id="xref-ref-19-3" hwp:rel-id="ref-19">19</xref>).</p><p hwp:id="p-41">Prior studies have observed regional alterations in gamma power in association with major depressive illness and bipolar disorder (<xref ref-type="bibr" rid="c29" hwp:id="xref-ref-29-1" hwp:rel-id="ref-29">29</xref>), as well as increases in gamma with spontaneous remission or selective serotonin reuptake inhibitor (SSRI) treatment in humans and rodent models (<xref ref-type="bibr" rid="c6" hwp:id="xref-ref-6-2" hwp:rel-id="ref-6">6</xref>, <xref ref-type="bibr" rid="c30" hwp:id="xref-ref-30-1" hwp:rel-id="ref-30">30</xref>). However, the role of PNN-degrading MMPs has not previously been explored as a mediator of enhanced gamma or antidepressant efficacy. Of interest, the SSRI fluoxetine has been linked to reductions in PNN integrity (<xref ref-type="bibr" rid="c13" hwp:id="xref-ref-13-2" hwp:rel-id="ref-13">13</xref>), and conversely, a recent study observed increased hippocampal PNN deposition in a chronic restraint stress rat model of depression (<xref ref-type="bibr" rid="c14" hwp:id="xref-ref-14-2" hwp:rel-id="ref-14">14</xref>). Moreover, exogenous chondroitinase, which degrades PNN components, improved stress-associated cognitive deficits in this model (<xref ref-type="bibr" rid="c14" hwp:id="xref-ref-14-3" hwp:rel-id="ref-14">14</xref>). In contrast, in mice that are deficient in the PNN protein neurocan, mania-like symptomatology with increased sucrose preference and reduced immobility in the forced swim test are observed (<xref ref-type="bibr" rid="c31" hwp:id="xref-ref-31-1" hwp:rel-id="ref-31">31</xref>). Also of relevance are human studies that have examined the PNN in the background of depression and observed alterations including PNN sulfation patterns that render the PNN more resistant to proteolysis (<xref ref-type="bibr" rid="c32" hwp:id="xref-ref-32-1" hwp:rel-id="ref-32">32</xref>).</p><p hwp:id="p-42">Changes in PNN integrity have the potential to influence oscillatory activity in varied brain regions. This specialized extracellular matrix (ECM) is predominantly localized to PV expressing fast spiking GABA releasing interneurons, which are in turn critical to rhythmic oscillations in the gamma frequency range. At the single cell level, disruption of the PNN has been linked to reduced glutamateric input to PV expressing interneurons (<xref ref-type="bibr" rid="c11" hwp:id="xref-ref-11-2" hwp:rel-id="ref-11">11</xref>) through mechanisms that may include increased lateral diffusion of GluAs and presynaptically released glutamate (<xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-3" hwp:rel-id="ref-10">10</xref>). Similarly, genetic deletion of the PNN component brevican has been associated with altered intrinsic properties and reduced synaptic input to PV interneurons through changes in potassium channel localization and levels of GluAs (<xref ref-type="bibr" rid="c33" hwp:id="xref-ref-33-1" hwp:rel-id="ref-33">33</xref>). Of interest, antidepressants including venlafaxine have been linked to an increased risk of seizures and disinhibition could contribute to the same.</p><p hwp:id="p-43">In terms of effects on population events to which PV activity contributes, PNN disruption has been shown to increase gamma power in the visual cortex (<xref ref-type="bibr" rid="c12" hwp:id="xref-ref-12-2" hwp:rel-id="ref-12">12</xref>). Indeed, chondroitinase removal of PNNs was shown to enhance both spontaneous gamma power in the 30–40 Hz range and monocular deprivation-linked gamma activity (<xref ref-type="bibr" rid="c12" hwp:id="xref-ref-12-3" hwp:rel-id="ref-12">12</xref>). These effects may seem at odds with the critical role that PV interneurons play in gamma and ripple generation, and with data linking knock down of GluA1 expression on PV cells to reduced gamma power (<xref ref-type="bibr" rid="c34" hwp:id="xref-ref-34-1" hwp:rel-id="ref-34">34</xref>). PNN attenuation, however, as opposed to a complete loss of this structure, could enhance gamma power through PC disinhibition in the background of PV cells that retain their ability to respond to the particularly strong rhythmic excitatory post synaptic potentials arising from pyramidal cells during oscillatory activity (<xref ref-type="bibr" rid="c35" hwp:id="xref-ref-35-1" hwp:rel-id="ref-35">35</xref>). Consistent with this are results linking a partial block of GluAs on interneurons to gamma generation (<xref ref-type="bibr" rid="c36" hwp:id="xref-ref-36-1" hwp:rel-id="ref-36">36</xref>). In addition, ketamine, which preferentially inhibits GluNs at fast spiking interneurons (<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-1" hwp:rel-id="ref-37">37</xref>), has been associated with increases in gamma power (<xref ref-type="bibr" rid="c38" hwp:id="xref-ref-38-1" hwp:rel-id="ref-38">38</xref>). Similarly, intermittent theta burst transcranial magnetic stimulation reduces PV expression and increases EEG gamma power (<xref ref-type="bibr" rid="c39" hwp:id="xref-ref-39-1" hwp:rel-id="ref-39">39</xref>). Furthermore, reducing NMDA mediated drive of cortical interneurons increases pyramidal cell firing rate (<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-2" hwp:rel-id="ref-37">37</xref>) and modeling studies are also consistent with a causative role for PV deficits in terms of oscillatory power (<xref ref-type="bibr" rid="c40" hwp:id="xref-ref-40-1" hwp:rel-id="ref-40">40</xref>).</p><p hwp:id="p-44">Despite potential similarities between effects of PNN disruption and models of reduced GABA mediated inhibition, we acknowledge that effects of chondroitinase and monoamine uptake inhibitors could be relatively complex. With respect to the latter, given the non-mutually exclusive potential for MMPs to enhance excitatory neurotransmission through relatively direct effects on PCs (<xref ref-type="bibr" rid="c41" hwp:id="xref-ref-41-1" hwp:rel-id="ref-41">41</xref>), future studies are warranted to parse out the relative contribution of PNN dependent and independent mechanisms to MMP associated changes in gamma power. One possibility would be to use PNN sulfation mutants that are relatively more resistant to proteolysis (<xref ref-type="bibr" rid="c42" hwp:id="xref-ref-42-1" hwp:rel-id="ref-42">42</xref>). It would also be of interest to evaluate gamma in PNN link protein mutants, which display juvenile plasticity and attenuated PNNs (<xref ref-type="bibr" rid="c43" hwp:id="xref-ref-43-1" hwp:rel-id="ref-43">43</xref>).</p><p hwp:id="p-45">In terms of the potential for increased gamma to contribute to antidepressant efficacy, we acknowledge that future behavioral studies will needed to address this issue. Gamma changes might simply represent a correlate of antidepressant efficacy. Given that increased gamma is observed not only with spontaneous remission but with improvements on the Hamilton Depression scale (<xref ref-type="bibr" rid="c30" hwp:id="xref-ref-30-2" hwp:rel-id="ref-30">30</xref>), however, the association is strong. Moreover, in a mouse model, deficits in gamma are inversely correlated with behavioral despair (<xref ref-type="bibr" rid="c40" hwp:id="xref-ref-40-2" hwp:rel-id="ref-40">40</xref>). In addition, gamma activity is thought to improve cognitive features that are impaired in major depressive disorder including short-term memory and attention (<xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-2" hwp:rel-id="ref-22">22</xref>). Of additional interest, depressed patients have poor dream recall as compared to controls (<xref ref-type="bibr" rid="c44" hwp:id="xref-ref-44-1" hwp:rel-id="ref-44">44</xref>), and both venlafaxine and increased gamma activity have independently been linked to lucid dreaming or enhanced dream recall (<xref ref-type="bibr" rid="c45" hwp:id="xref-ref-45-1" hwp:rel-id="ref-45">45</xref>, <xref ref-type="bibr" rid="c46" hwp:id="xref-ref-46-1" hwp:rel-id="ref-46">46</xref>). An unanswered question, however, relates to whether antidepressant associated changes in gamma activity would be wholly beneficial.</p><p hwp:id="p-46">In experiments herein, we focused on carbachol-induced gamma in the hippocampus, a region that has been increasing implicated in MDD (reviewed in (<xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-3" hwp:rel-id="ref-22">22</xref>)). For example, depression can be induced by stress in varied rodent models and the hippocampus is sensitive to stress induced atrophy (<xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-4" hwp:rel-id="ref-22">22</xref>). Moreover, hippocampal dependent functions including explicit memory are impaired with depression (<xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-5" hwp:rel-id="ref-22">22</xref>). The hippocampus is also part of a functional network, which includes regions such as prefrontal cortex, that is dysregulated in MDD (<xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-6" hwp:rel-id="ref-22">22</xref>). Of interest, the hippocampus is also the focus of a study examining kainate-induced gamma in <italic toggle="yes">ex vivo</italic> rat slices following acute or chronic administration of fluoxetine or imipramine (<xref ref-type="bibr" rid="c47" hwp:id="xref-ref-47-1" hwp:rel-id="ref-47">47</xref>). Differences in species and animal ages, which influence PNN levels (<xref ref-type="bibr" rid="c16" hwp:id="xref-ref-16-5" hwp:rel-id="ref-16">16</xref>, <xref ref-type="bibr" rid="c18" hwp:id="xref-ref-18-8" hwp:rel-id="ref-18">18</xref>), may confound direct comparisons with the present study, as may the use of alternate antidepressants and a different gamma-inducing stimulus. Interestingly, however, while gamma power in chronically treated rats was not increased when examined over a broad range, the power trace for fluoxetine at frequencies below 40 Hz was elevated relative to control and imipramine (<xref ref-type="bibr" rid="c47" hwp:id="xref-ref-47-2" hwp:rel-id="ref-47">47</xref>).</p><p hwp:id="p-47">Herein we also focused on evaluation of gamma in <italic toggle="yes">ex vivo</italic> slices after chronic antidepressant administration. Monoamine reuptake inhibitors typically require several weeks to show a clinical benefit. We posit that changes in PNN integrity could take days to weeks to develop but future studies will be necessary to address the time course by which venlafaxine influences PNN integrity. Importantly, however, we note that acute treatment of <italic toggle="yes">ex vivo</italic> hippocampal slices with monoamines or serotonin reuptake inhibitors can reduce gamma power suggesting that results described in the present study are likely due to changes that follow chronic as opposed to acute antidepressant exposure (<xref ref-type="bibr" rid="c47" hwp:id="xref-ref-47-3" hwp:rel-id="ref-47">47</xref>–<xref ref-type="bibr" rid="c49" hwp:id="xref-ref-49-1" hwp:rel-id="ref-49">49</xref>).</p><p hwp:id="p-48">While our study also demonstrated increased MMP-9 in the CNS of venlafaxine treated animals as well as MMP-9 dependent diminution of the PNN, we acknowledge that other MMPs may contribute to venlafaxine-associated changes in the PNN. This is supported by the observation that the PV/PNN ratio is also increased in the venlafaxine treated knockouts in one analysis (Student’s t-test versus ANOVA). The observation that ratio differences are more robust in the wild type, however, is not unexpected. As compared to other family members, neurons express high levels of MMP-9 when stimulated with glutamate or monoamines (<xref ref-type="bibr" rid="c19" hwp:id="xref-ref-19-4" hwp:rel-id="ref-19">19</xref>, <xref ref-type="bibr" rid="c28" hwp:id="xref-ref-28-2" hwp:rel-id="ref-28">28</xref>). MMP-9 is also rapidly transcribed with neuronal activity and LTP (<xref ref-type="bibr" rid="c26" hwp:id="xref-ref-26-2" hwp:rel-id="ref-26">26</xref>, <xref ref-type="bibr" rid="c28" hwp:id="xref-ref-28-3" hwp:rel-id="ref-28">28</xref>), and the latter may be enhanced by monoamines (<xref ref-type="bibr" rid="c19" hwp:id="xref-ref-19-5" hwp:rel-id="ref-19">19</xref>). It is thus possible that localized increases in monoamine levels can increase neuronal expression of MMP-9 in a relatively selective manner. Light reintroduction and FXS related changes in fragile X mental retardation protein may do the same (<xref ref-type="bibr" rid="c50" hwp:id="xref-ref-50-1" hwp:rel-id="ref-50">50</xref>), and MMP-9 has been implicated in the PNN remodeling that occurs in both settings (<xref ref-type="bibr" rid="c16" hwp:id="xref-ref-16-6" hwp:rel-id="ref-16">16</xref>), (<xref ref-type="bibr" rid="c18" hwp:id="xref-ref-18-9" hwp:rel-id="ref-18">18</xref>). Once upregulated, MMP-9 could also activate additional metalloproteinases that can in turn process PNN components.</p><p hwp:id="p-49">In summary, we have shown that chronic treatment with the monoamine reuptake inhibitor venlafaxine increases PNN proteolysis and gamma power in murine hippocampus. We suggest that future studies are warranted to determine whether PNN proteolysis contributes to antidepressant efficacy. While we acknowledge that not all patients respond to monoamine reuptake inhibitors, these medications are effective in a substantial percentage. The identification of new molecular targets could thus lead to the design of drugs or combination therapies. Our results raise the possibility that preferential targeting of GPCRs which best activate signaling molecules linked to increased MMP expression might be pursued.</p></sec></body><back><ack hwp:id="ack-1"><title hwp:id="title-25">Acknowledgements</title><p hwp:id="p-50">We would like to acknowledge outstanding veterinary support from the Department of Comparative Medicine and we would also like to apologize to investigators whose excellent work could not be directly cited due to publisher limits.</p></ack><sec hwp:id="sec-19"><title hwp:id="title-26">Funding and Disclosure Funding and Disclosure</title><p hwp:id="p-51">Katherine Conant received funds for support and supplies from the Georgetown University <italic toggle="yes">Partners in Research</italic> program. Seham Alaiyed received support from the Saudi Arabian government, Qassim University scholarship program. P. Lorenzo Bozzelli was supported with funding from T32 NS041218 and Adam Caccavano was supported by the NIH/NCATS, TL1TR001431. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. There are no competing financial interests for any of the authors in relation to the work described.</p></sec><ref-list hwp:id="ref-list-1"><title hwp:id="title-27">References</title><ref id="c1" hwp:id="ref-1" hwp:rev-id="xref-ref-1-1"><label>1.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.1" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-1"><string-name name-style="western" hwp:sortable="Ownby R. L."><surname>Ownby</surname>, <given-names>R. L.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Crocco E."><surname>Crocco</surname>, <given-names>E.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Acevedo A."><surname>Acevedo</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="John V."><surname>John</surname>, <given-names>V.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Loewenstein D."><surname>Loewenstein</surname>, <given-names>D.</given-names></string-name> (<year>2006</year>) <article-title hwp:id="article-title-2">Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis</article-title>. <source hwp:id="source-1">Arch Gen Psychiatry</source> <volume>63</volume>, <fpage>530</fpage>–<lpage>538</lpage></citation></ref><ref id="c2" hwp:id="ref-2" hwp:rev-id="xref-ref-2-1"><label>2.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.2" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-2"><string-name name-style="western" hwp:sortable="Quello S. B."><surname>Quello</surname>, <given-names>S. B.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Brady K. T."><surname>Brady</surname>, <given-names>K. T.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Sonne S. C."><surname>Sonne</surname>, <given-names>S. C.</given-names></string-name> (<year>2005</year>) <article-title hwp:id="article-title-3">Mood disorders and substance use disorder: a complex comorbidity</article-title>. <source hwp:id="source-2">Sci Pract Perspect</source> <volume>3</volume>, <fpage>13</fpage>–<lpage>21</lpage></citation></ref><ref id="c3" hwp:id="ref-3" hwp:rev-id="xref-ref-3-1 xref-ref-3-2"><label>3.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.3" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-3"><string-name name-style="western" hwp:sortable="Thompson S. M."><surname>Thompson</surname>, <given-names>S. M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kallarackal A. J."><surname>Kallarackal</surname>, <given-names>A. J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kvarta M. D."><surname>Kvarta</surname>, <given-names>M. D.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Van Dyke A. M."><surname>Van Dyke</surname>, <given-names>A. M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="LeGates T. A."><surname>LeGates</surname>, <given-names>T. A.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Cai X."><surname>Cai</surname>, <given-names>X.</given-names></string-name> (<year>2015</year>) <article-title hwp:id="article-title-4">An excitatory synapse hypothesis of depression</article-title>. <source hwp:id="source-3">Trends Neurosci</source> <volume>38</volume>, <fpage>279</fpage>–<lpage>294</lpage></citation></ref><ref id="c4" hwp:id="ref-4" hwp:rev-id="xref-ref-4-1"><label>4.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.4" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-4"><string-name name-style="western" hwp:sortable="Chen F."><surname>Chen</surname>, <given-names>F.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Madsen T. M."><surname>Madsen</surname>, <given-names>T. M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wegener G."><surname>Wegener</surname>, <given-names>G.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Nyengaard J. R."><surname>Nyengaard</surname>, <given-names>J. R.</given-names></string-name> (<year>2010</year>) <article-title hwp:id="article-title-5">Imipramine treatment increases the number of hippocampal synapses and neurons in a genetic animal model of depression</article-title>. <source hwp:id="source-4">Hippocampus</source> <volume>20</volume>, <fpage>1376</fpage>–<lpage>1384</lpage></citation></ref><ref id="c5" hwp:id="ref-5" hwp:rev-id="xref-ref-5-1 xref-ref-5-2"><label>5.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.5" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-5"><string-name name-style="western" hwp:sortable="Zanos P."><surname>Zanos</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Nelson M. E."><surname>Nelson</surname>, <given-names>M. E.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Highland J. N."><surname>Highland</surname>, <given-names>J. N.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Krimmel S. R."><surname>Krimmel</surname>, <given-names>S. R.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Georgiou P."><surname>Georgiou</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gould T. D."><surname>Gould</surname>, <given-names>T. D.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Thompson S. M."><surname>Thompson</surname>, <given-names>S. M.</given-names></string-name> (<year>2017</year>) <article-title hwp:id="article-title-6">A Negative Allosteric Modulator for alpha5 Subunit-Containing GABA Receptors Exerts a Rapid and Persistent Antidepressant-Like Action without the Side Effects of the NMDA Receptor Antagonist Ketamine in Mice</article-title>. <source hwp:id="source-5">eNeuro</source> <volume>4</volume></citation></ref><ref id="c6" hwp:id="ref-6" hwp:rev-id="xref-ref-6-1 xref-ref-6-2"><label>6.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.6" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-6"><string-name name-style="western" hwp:sortable="Khalid A."><surname>Khalid</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kim B. S."><surname>Kim</surname>, <given-names>B. S.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Seo B. A."><surname>Seo</surname>, <given-names>B. A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lee S. T."><surname>Lee</surname>, <given-names>S. T.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Jung K. H."><surname>Jung</surname>, <given-names>K. H.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chu K."><surname>Chu</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lee S. K."><surname>Lee</surname>, <given-names>S. K.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Jeon D."><surname>Jeon</surname>, <given-names>D.</given-names></string-name> (<year>2016</year>) <article-title hwp:id="article-title-7">Gamma oscillation in functional brain networks is involved in the spontaneous remission of depressive behavior induced by chronic restraint stress in mice</article-title>. <source hwp:id="source-6">BMC Neurosci</source> <volume>17</volume>, <fpage>4</fpage></citation></ref><ref id="c7" hwp:id="ref-7" hwp:rev-id="xref-ref-7-1 xref-ref-7-2"><label>7.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.7" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-7"><string-name name-style="western" hwp:sortable="Fitzgerald P. J."><surname>Fitzgerald</surname>, <given-names>P. J.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Watson B. O."><surname>Watson</surname>, <given-names>B. O.</given-names></string-name> (<year>2018</year>) <article-title hwp:id="article-title-8">Gamma oscillations as a biomarker for major depression: an emerging topic</article-title>. <source hwp:id="source-7">Transl Psychiatry</source> <volume>8</volume>, <fpage>177</fpage></citation></ref><ref id="c8" hwp:id="ref-8" hwp:rev-id="xref-ref-8-1"><label>8.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.8" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-8"><string-name name-style="western" hwp:sortable="Lensjo K. K."><surname>Lensjo</surname>, <given-names>K. K.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Christensen A. C."><surname>Christensen</surname>, <given-names>A. C.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tennoe S."><surname>Tennoe</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fyhn M."><surname>Fyhn</surname>, <given-names>M.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Hafting T."><surname>Hafting</surname>, <given-names>T.</given-names></string-name> (<year>2017</year>) <article-title hwp:id="article-title-9">Differential Expression and Cell-Type Specificity of Perineuronal Nets in Hippocampus, Medial Entorhinal Cortex, and Visual Cortex Examined in the Rat and Mouse</article-title>. <source hwp:id="source-8">eNeuro</source> <volume>4</volume></citation></ref><ref id="c9" hwp:id="ref-9" hwp:rev-id="xref-ref-9-1"><label>9.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.9" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-9"><string-name name-style="western" hwp:sortable="Sorg B. A."><surname>Sorg</surname>, <given-names>B. A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Berretta S."><surname>Berretta</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Blacktop J. M."><surname>Blacktop</surname>, <given-names>J. M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fawcett J. W."><surname>Fawcett</surname>, <given-names>J. W.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kitagawa H."><surname>Kitagawa</surname>, <given-names>H.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kwok J. C."><surname>Kwok</surname>, <given-names>J. C.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Miquel M."><surname>Miquel</surname>, <given-names>M.</given-names></string-name> (<year>2016</year>) <article-title hwp:id="article-title-10">Casting a Wide Net: Role of Perineuronal Nets in Neural Plasticity</article-title>. <source hwp:id="source-9">J Neurosci</source> <volume>36</volume>, <fpage>11459</fpage>–<lpage>11468</lpage></citation></ref><ref id="c10" hwp:id="ref-10" hwp:rev-id="xref-ref-10-1 xref-ref-10-2 xref-ref-10-3"><label>10.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.10" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-10"><string-name name-style="western" hwp:sortable="Frischknecht R."><surname>Frischknecht</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Heine M."><surname>Heine</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Perrais D."><surname>Perrais</surname>, <given-names>D.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Seidenbecher C. I."><surname>Seidenbecher</surname>, <given-names>C. I.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Choquet D."><surname>Choquet</surname>, <given-names>D.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Gundelfinger E. D."><surname>Gundelfinger</surname>, <given-names>E. D.</given-names></string-name> (<year>2009</year>) <article-title hwp:id="article-title-11">Brain extracellular matrix affects AMPA receptor lateral mobility and short-term synaptic plasticity</article-title>. <source hwp:id="source-10">Nat Neurosci</source> <volume>12</volume>, <fpage>897</fpage>–<lpage>904</lpage></citation></ref><ref id="c11" hwp:id="ref-11" hwp:rev-id="xref-ref-11-1 xref-ref-11-2"><label>11.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.11" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-11"><string-name name-style="western" hwp:sortable="Hayani H."><surname>Hayani</surname>, <given-names>H.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Song I."><surname>Song</surname>, <given-names>I.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Dityatev A."><surname>Dityatev</surname>, <given-names>A.</given-names></string-name> (<year>2018</year>) <article-title hwp:id="article-title-12">Increased Excitability and Reduced Excitatory Synaptic Input Into Fast-Spiking CA2 Interneurons After Enzymatic Attenuation of Extracellular Matrix</article-title>. <source hwp:id="source-11">Front Cell Neurosci</source> <volume>12</volume>, <fpage>149</fpage></citation></ref><ref id="c12" hwp:id="ref-12" hwp:rev-id="xref-ref-12-1 xref-ref-12-2 xref-ref-12-3"><label>12.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.12" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-12"><string-name name-style="western" hwp:sortable="Lensjo K. K."><surname>Lensjo</surname>, <given-names>K. K.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lepperod M. E."><surname>Lepperod</surname>, <given-names>M. E.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dick G."><surname>Dick</surname>, <given-names>G.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hafting T."><surname>Hafting</surname>, <given-names>T.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Fyhn M."><surname>Fyhn</surname>, <given-names>M.</given-names></string-name> (<year>2017</year>) <article-title hwp:id="article-title-13">Removal of Perineuronal Nets Unlocks Juvenile Plasticity Through Network Mechanisms of Decreased Inhibition and Increased Gamma Activity</article-title>. <source hwp:id="source-12">J Neurosci</source> <volume>37</volume>, <fpage>1269</fpage>–<lpage>1283</lpage></citation></ref><ref id="c13" hwp:id="ref-13" hwp:rev-id="xref-ref-13-1 xref-ref-13-2"><label>13.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.13" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-13"><string-name name-style="western" hwp:sortable="Ohira K."><surname>Ohira</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Takeuchi R."><surname>Takeuchi</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Iwanaga T."><surname>Iwanaga</surname>, <given-names>T.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Miyakawa T."><surname>Miyakawa</surname>, <given-names>T.</given-names></string-name> (<year>2013</year>) <article-title hwp:id="article-title-14">Chronic fluoxetine treatment reduces parvalbumin expression and perineuronal nets in gamma-aminobutyric acidergic interneurons of the frontal cortex in adult mice</article-title>. <source hwp:id="source-13">Mol Brain</source> <volume>6</volume>, <fpage>43</fpage></citation></ref><ref id="c14" hwp:id="ref-14" hwp:rev-id="xref-ref-14-1 xref-ref-14-2 xref-ref-14-3"><label>14.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.14" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-14"><string-name name-style="western" hwp:sortable="Riga D."><surname>Riga</surname>, <given-names>D.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kramvis I."><surname>Kramvis</surname>, <given-names>I.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Koskinen M. K."><surname>Koskinen</surname>, <given-names>M. K.</given-names></string-name>, <string-name name-style="western" hwp:sortable="van Bokhoven P."><surname>van Bokhoven</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western" hwp:sortable="van der Harst J. E."><surname>van der Harst</surname>, <given-names>J. E.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Heistek T. S."><surname>Heistek</surname>, <given-names>T. S.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Jaap Timmerman A."><surname>Jaap Timmerman</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="van Nierop P."><surname>van Nierop</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western" hwp:sortable="van der Schors R. C."><surname>van der Schors</surname>, <given-names>R. C.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pieneman A. W."><surname>Pieneman</surname>, <given-names>A. W.</given-names></string-name>, <string-name name-style="western" hwp:sortable="de Weger A."><surname>de Weger</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="van Mourik Y."><surname>van Mourik</surname>, <given-names>Y.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Schoffelmeer A. N. M."><surname>Schoffelmeer</surname>, <given-names>A. N. M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mansvelder H. D."><surname>Mansvelder</surname>, <given-names>H. D.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Meredith R. M."><surname>Meredith</surname>, <given-names>R. M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hoogendijk W. J. G."><surname>Hoogendijk</surname>, <given-names>W. J. G.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Smit A. B."><surname>Smit</surname>, <given-names>A. B.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Spijker S."><surname>Spijker</surname>, <given-names>S.</given-names></string-name> (<year>2017</year>) <article-title hwp:id="article-title-15">Hippocampal extracellular matrix alterations contribute to cognitive impairment associated with a chronic depressive-like state in rats</article-title>. <source hwp:id="source-14">Sci Transl Med</source> <fpage>9</fpage></citation></ref><ref id="c15" hwp:id="ref-15" hwp:rev-id="xref-ref-15-1"><label>15.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.15" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-15"><string-name name-style="western" hwp:sortable="Lorenzo Bozzelli P."><surname>Lorenzo Bozzelli</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Alaiyed S."><surname>Alaiyed</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kim E."><surname>Kim</surname>, <given-names>E.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Villapol S."><surname>Villapol</surname>, <given-names>S.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Conant K."><surname>Conant</surname>, <given-names>K.</given-names></string-name> (<year>2018</year>) <article-title hwp:id="article-title-16">Proteolytic Remodeling of Perineuronal Nets: Effects on Synaptic Plasticity and Neuronal Population Dynamics</article-title>. <source hwp:id="source-15">Neural Plast</source> 2018, <fpage>5735789</fpage></citation></ref><ref id="c16" hwp:id="ref-16" hwp:rev-id="xref-ref-16-1 xref-ref-16-2 xref-ref-16-3 xref-ref-16-4 xref-ref-16-5 xref-ref-16-6"><label>16.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.16" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-16"><string-name name-style="western" hwp:sortable="Murase S."><surname>Murase</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lantz C. L."><surname>Lantz</surname>, <given-names>C. L.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Quinlan E. M."><surname>Quinlan</surname>, <given-names>E. M.</given-names></string-name> (<year>2017</year>) <article-title hwp:id="article-title-17">Light reintroduction after dark exposure reactivates plasticity in adults via perisynaptic activation of MMP-9</article-title>. <source hwp:id="source-16">Elife</source> <volume>6</volume></citation></ref><ref id="c17" hwp:id="ref-17" hwp:rev-id="xref-ref-17-1"><label>17.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.17" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-17"><string-name name-style="western" hwp:sortable="Pollock E."><surname>Pollock</surname>, <given-names>E.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Everest M."><surname>Everest</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Brown A."><surname>Brown</surname>, <given-names>A.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Poulter M. O."><surname>Poulter</surname>, <given-names>M. O.</given-names></string-name> (<year>2014</year>) <article-title hwp:id="article-title-18">Metalloproteinase inhibition prevents inhibitory synapse reorganization and seizure genesis</article-title>. <source hwp:id="source-17">Neurobiol Dis</source> <volume>70</volume>, <fpage>21</fpage>–<lpage>31</lpage></citation></ref><ref id="c18" hwp:id="ref-18" hwp:rev-id="xref-ref-18-1 xref-ref-18-2 xref-ref-18-3 xref-ref-18-4 xref-ref-18-5 xref-ref-18-6 xref-ref-18-7 xref-ref-18-8 xref-ref-18-9"><label>18.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.18" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-18"><string-name name-style="western" hwp:sortable="Wen T. H."><surname>Wen</surname>, <given-names>T. H.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Afroz S."><surname>Afroz</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Reinhard S. M."><surname>Reinhard</surname>, <given-names>S. M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Palacios A. R."><surname>Palacios</surname>, <given-names>A. R.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tapia K."><surname>Tapia</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Binder D. K."><surname>Binder</surname>, <given-names>D. K.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Razak K. A."><surname>Razak</surname>, <given-names>K. A.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Ethell I. M."><surname>Ethell</surname>, <given-names>I. M.</given-names></string-name> (<year>2017</year>) <article-title hwp:id="article-title-19">Genetic Reduction of Matrix Metalloproteinase-9 Promotes Formation of Perineuronal Nets Around Parvalbumin-Expressing Interneurons and Normalizes Auditory Cortex Responses in Developing Fmr1 Knock-Out Mice</article-title>. <source hwp:id="source-18">Cereb Cortex</source>, <fpage>1</fpage>–<lpage>14</lpage></citation></ref><ref id="c19" hwp:id="ref-19" hwp:rev-id="xref-ref-19-1 xref-ref-19-2 xref-ref-19-3 xref-ref-19-4 xref-ref-19-5"><label>19.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.19" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-19"><string-name name-style="western" hwp:sortable="Bijata M."><surname>Bijata</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Labus J."><surname>Labus</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Guseva D."><surname>Guseva</surname>, <given-names>D.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Stawarski M."><surname>Stawarski</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Butzlaff M."><surname>Butzlaff</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dzwonek J."><surname>Dzwonek</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Schneeberg J."><surname>Schneeberg</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bohm K."><surname>Bohm</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Michaluk P."><surname>Michaluk</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rusakov D. A."><surname>Rusakov</surname>, <given-names>D. A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dityatev A."><surname>Dityatev</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wilczynski G."><surname>Wilczynski</surname>, <given-names>G.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wlodarczyk J."><surname>Wlodarczyk</surname>, <given-names>J.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Ponimaskin E."><surname>Ponimaskin</surname>, <given-names>E.</given-names></string-name> (<year>2017</year>) <article-title hwp:id="article-title-20">Synaptic Remodeling Depends on Signaling between Serotonin Receptors and the Extracellular Matrix</article-title>. <source hwp:id="source-19">Cell Rep</source> <volume>19</volume>, <fpage>1767</fpage>–<lpage>1782</lpage></citation></ref><ref id="c20" hwp:id="ref-20" hwp:rev-id="xref-ref-20-1 xref-ref-20-2"><label>20.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.20" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-20"><string-name name-style="western" hwp:sortable="Tamasi V."><surname>Tamasi</surname>, <given-names>V.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Petschner P."><surname>Petschner</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Adori C."><surname>Adori</surname>, <given-names>C.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kirilly E."><surname>Kirilly</surname>, <given-names>E.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ando R. D."><surname>Ando</surname>, <given-names>R. D.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tothfalusi L."><surname>Tothfalusi</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Juhasz G."><surname>Juhasz</surname>, <given-names>G.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Bagdy G."><surname>Bagdy</surname>, <given-names>G.</given-names></string-name> (<year>2014</year>) <article-title hwp:id="article-title-21">Transcriptional evidence for the role of chronic venlafaxine treatment in neurotrophic signaling and neuroplasticity including also Glutamatergic [corrected] –and insulin-mediated neuronal processes</article-title>. <source hwp:id="source-20">PLoS One</source> <volume>9</volume>, <fpage>e113662</fpage></citation></ref><ref id="c21" hwp:id="ref-21" hwp:rev-id="xref-ref-21-1"><label>21.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.21" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-21"><string-name name-style="western" hwp:sortable="Yang E. V."><surname>Yang</surname>, <given-names>E. V.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sood A. K."><surname>Sood</surname>, <given-names>A. K.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chen M."><surname>Chen</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Li Y."><surname>Li</surname>, <given-names>Y.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Eubank T. D."><surname>Eubank</surname>, <given-names>T. D.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Marsh C. B."><surname>Marsh</surname>, <given-names>C. B.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Jewell S."><surname>Jewell</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Flavahan N. A."><surname>Flavahan</surname>, <given-names>N. A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Morrison C."><surname>Morrison</surname>, <given-names>C.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Yeh P. E."><surname>Yeh</surname>, <given-names>P. E.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lemeshow S."><surname>Lemeshow</surname>, <given-names>S.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Glaser R."><surname>Glaser</surname>, <given-names>R.</given-names></string-name> (<year>2006</year>) <article-title hwp:id="article-title-22">Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells</article-title>. <source hwp:id="source-21">Cancer Res</source> <volume>66</volume>, <fpage>10357</fpage>–<lpage>10364</lpage></citation></ref><ref id="c22" hwp:id="ref-22" hwp:rev-id="xref-ref-22-1 xref-ref-22-2 xref-ref-22-3 xref-ref-22-4 xref-ref-22-5 xref-ref-22-6"><label>22.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.22" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-22"><string-name name-style="western" hwp:sortable="MacQueen G."><surname>MacQueen</surname>, <given-names>G.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Frodl T."><surname>Frodl</surname>, <given-names>T.</given-names></string-name> (<year>2011</year>) <article-title hwp:id="article-title-23">The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research?</article-title> <source hwp:id="source-22">Mol Psychiatry</source> <volume>16</volume>, <fpage>252</fpage>–<lpage>264</lpage></citation></ref><ref id="c23" hwp:id="ref-23" hwp:rev-id="xref-ref-23-1"><label>23.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.23" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-23"><string-name name-style="western" hwp:sortable="David D. J."><surname>David</surname>, <given-names>D. J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bourin M."><surname>Bourin</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Jego G."><surname>Jego</surname>, <given-names>G.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Przybylski C."><surname>Przybylski</surname>, <given-names>C.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Jolliet P."><surname>Jolliet</surname>, <given-names>P.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Gardier A. M."><surname>Gardier</surname>, <given-names>A. M.</given-names></string-name> (<year>2003</year>) <article-title hwp:id="article-title-24">Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss mice</article-title>. <source hwp:id="source-23">Br J Pharmacol</source> <volume>140</volume>, <fpage>1128</fpage>–<lpage>1136</lpage></citation></ref><ref id="c24" hwp:id="ref-24" hwp:rev-id="xref-ref-24-1"><label>24.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.24" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-24"><string-name name-style="western" hwp:sortable="Nibuya M."><surname>Nibuya</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Nestler E. J."><surname>Nestler</surname>, <given-names>E. J.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Duman R. S."><surname>Duman</surname>, <given-names>R. S.</given-names></string-name> (<year>1996</year>) <article-title hwp:id="article-title-25">Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus</article-title>. <source hwp:id="source-24">J Neurosci</source> <volume>16</volume>, <fpage>2365</fpage>–<lpage>2372</lpage></citation></ref><ref id="c25" hwp:id="ref-25" hwp:rev-id="xref-ref-25-1 xref-ref-25-2"><label>25.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.25" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-25"><string-name name-style="western" hwp:sortable="Fisahn A."><surname>Fisahn</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pike F. G."><surname>Pike</surname>, <given-names>F. G.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Buhl E. H."><surname>Buhl</surname>, <given-names>E. H.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Paulsen O."><surname>Paulsen</surname>, <given-names>O.</given-names></string-name> (<year>1998</year>) <article-title hwp:id="article-title-26">Cholinergic induction of network oscillations at 40 Hz in the hippocampus in vitro</article-title>. <source hwp:id="source-25">Nature</source> <volume>394</volume>, <fpage>186</fpage>–<lpage>189</lpage></citation></ref><ref id="c26" hwp:id="ref-26" hwp:rev-id="xref-ref-26-1 xref-ref-26-2"><label>26.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.26" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-26"><string-name name-style="western" hwp:sortable="Nagy V."><surname>Nagy</surname>, <given-names>V.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bozdagi O."><surname>Bozdagi</surname>, <given-names>O.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Matynia A."><surname>Matynia</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Balcerzyk M."><surname>Balcerzyk</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Okulski P."><surname>Okulski</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dzwonek J."><surname>Dzwonek</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Costa R. M."><surname>Costa</surname>, <given-names>R. M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Silva A. J."><surname>Silva</surname>, <given-names>A. J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kaczmarek L."><surname>Kaczmarek</surname>, <given-names>L.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Huntley G. W."><surname>Huntley</surname>, <given-names>G. W.</given-names></string-name> (<year>2006</year>) <article-title hwp:id="article-title-27">Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory</article-title>. <source hwp:id="source-26">J Neurosci</source> <volume>26</volume>, <fpage>1923</fpage>–<lpage>1934</lpage></citation></ref><ref id="c27" hwp:id="ref-27" hwp:rev-id="xref-ref-27-1"><label>27.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.27" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-27"><string-name name-style="western" hwp:sortable="Ferrer-Ferrer M."><surname>Ferrer-Ferrer</surname>, <given-names>M.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Dityatev A."><surname>Dityatev</surname>, <given-names>A.</given-names></string-name> (<year>2018</year>) <article-title hwp:id="article-title-28">Shaping Synapses by the Neural Extracellular Matrix</article-title>. <source hwp:id="source-27">Front Neuroanat</source> <volume>12</volume>, <fpage>40</fpage></citation></ref><ref id="c28" hwp:id="ref-28" hwp:rev-id="xref-ref-28-1 xref-ref-28-2 xref-ref-28-3"><label>28.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.28" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-28"><string-name name-style="western" hwp:sortable="Dziembowska M."><surname>Dziembowska</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Milek J."><surname>Milek</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Janusz A."><surname>Janusz</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rejmak E."><surname>Rejmak</surname>, <given-names>E.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Romanowska E."><surname>Romanowska</surname>, <given-names>E.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gorkiewicz T."><surname>Gorkiewicz</surname>, <given-names>T.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tiron A."><surname>Tiron</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bramham C. R."><surname>Bramham</surname>, <given-names>C. R.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Kaczmarek L."><surname>Kaczmarek</surname>, <given-names>L.</given-names></string-name> (<year>2012</year>) <article-title hwp:id="article-title-29">Activity-dependent local translation of matrix metalloproteinase-9</article-title>. <source hwp:id="source-28">J Neurosci</source> <volume>32</volume>, <fpage>14538</fpage>–<lpage>14547</lpage></citation></ref><ref id="c29" hwp:id="ref-29" hwp:rev-id="xref-ref-29-1"><label>29.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.29" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-29"><string-name name-style="western" hwp:sortable="Liu T. Y."><surname>Liu</surname>, <given-names>T. Y.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hsieh J. C."><surname>Hsieh</surname>, <given-names>J. C.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chen Y. S."><surname>Chen</surname>, <given-names>Y. S.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tu P. C."><surname>Tu</surname>, <given-names>P. C.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Su T. P."><surname>Su</surname>, <given-names>T. P.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Chen L. F."><surname>Chen</surname>, <given-names>L. F.</given-names></string-name> (<year>2012</year>) <article-title hwp:id="article-title-30">Different patterns of abnormal gamma oscillatory activity in unipolar and bipolar disorder patients during an implicit emotion task</article-title>. <source hwp:id="source-29">Neuropsychologia</source> <volume>50</volume>, <fpage>1514</fpage>–<lpage>1520</lpage></citation></ref><ref id="c30" hwp:id="ref-30" hwp:rev-id="xref-ref-30-1 xref-ref-30-2"><label>30.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.30" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-30"><string-name name-style="western" hwp:sortable="Arikan M. K."><surname>Arikan</surname>, <given-names>M. K.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Metin B."><surname>Metin</surname>, <given-names>B.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Tarhan N."><surname>Tarhan</surname>, <given-names>N.</given-names></string-name> (<year>2018</year>) <article-title hwp:id="article-title-31">EEG gamma synchronization is associated with response to paroxetine treatment</article-title>. <source hwp:id="source-30">J Affect Disord</source> <volume>235</volume>, <fpage>114</fpage>–<lpage>116</lpage></citation></ref><ref id="c31" hwp:id="ref-31" hwp:rev-id="xref-ref-31-1"><label>31.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.31" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-31"><string-name name-style="western" hwp:sortable="Miro X."><surname>Miro</surname>, <given-names>X.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Meier S."><surname>Meier</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dreisow M. L."><surname>Dreisow</surname>, <given-names>M. L.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Frank J."><surname>Frank</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Strohmaier J."><surname>Strohmaier</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Breuer R."><surname>Breuer</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Schmal C."><surname>Schmal</surname>, <given-names>C.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Albayram O."><surname>Albayram</surname>, <given-names>O.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pardo-Olmedilla M. T."><surname>Pardo-Olmedilla</surname>, <given-names>M. T.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Muhleisen T. W."><surname>Muhleisen</surname>, <given-names>T. W.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Degenhardt F. A."><surname>Degenhardt</surname>, <given-names>F. A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mattheisen M."><surname>Mattheisen</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Reinhard I."><surname>Reinhard</surname>, <given-names>I.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bilkei-Gorzo A."><surname>Bilkei-Gorzo</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cichon S."><surname>Cichon</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Seidenbecher C."><surname>Seidenbecher</surname>, <given-names>C.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rietschel M."><surname>Rietschel</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Nothen M. M."><surname>Nothen</surname>, <given-names>M. M.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Zimmer A."><surname>Zimmer</surname>, <given-names>A.</given-names></string-name> (<year>2012</year>) <article-title hwp:id="article-title-32">Studies in humans and mice implicate neurocan in the etiology of mania</article-title>. <source hwp:id="source-31">Am J Psychiatry</source> <volume>169</volume>, <fpage>982</fpage>–<lpage>990</lpage></citation></ref><ref id="c32" hwp:id="ref-32" hwp:rev-id="xref-ref-32-1"><label>32.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.32" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-32"><string-name name-style="western" hwp:sortable="Pantazopoulos H."><surname>Pantazopoulos</surname>, <given-names>H.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Markota M."><surname>Markota</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Jaquet F."><surname>Jaquet</surname>, <given-names>F.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ghosh D."><surname>Ghosh</surname>, <given-names>D.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wallin A."><surname>Wallin</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Santos A."><surname>Santos</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Caterson B."><surname>Caterson</surname>, <given-names>B.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Berretta S."><surname>Berretta</surname>, <given-names>S.</given-names></string-name> (<year>2015</year>) <article-title hwp:id="article-title-33">Aggrecan and chondroitin-6-sulfate abnormalities in schizophrenia and bipolar disorder: a postmortem study on the amygdala</article-title>. <source hwp:id="source-32">Transl Psychiatry</source> <volume>5</volume>, <fpage>e496</fpage></citation></ref><ref id="c33" hwp:id="ref-33" hwp:rev-id="xref-ref-33-1"><label>33.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.33" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-33"><string-name name-style="western" hwp:sortable="Favuzzi E."><surname>Favuzzi</surname>, <given-names>E.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Marques-Smith A."><surname>Marques-Smith</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Deogracias R."><surname>Deogracias</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Winterflood C. M."><surname>Winterflood</surname>, <given-names>C. M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sanchez-Aguilera A."><surname>Sanchez-Aguilera</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mantoan L."><surname>Mantoan</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Maeso P."><surname>Maeso</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fernandes C."><surname>Fernandes</surname>, <given-names>C.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ewers H."><surname>Ewers</surname>, <given-names>H.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Rico B."><surname>Rico</surname>, <given-names>B.</given-names></string-name> (<year>2017</year>) <article-title hwp:id="article-title-34">Activity-Dependent Gating of Parvalbumin Interneuron Function by the Perineuronal Net Protein Brevican</article-title>. <source hwp:id="source-33">Neuron</source></citation></ref><ref id="c34" hwp:id="ref-34" hwp:rev-id="xref-ref-34-1"><label>34.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.34" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-34"><string-name name-style="western" hwp:sortable="Fuchs E. C."><surname>Fuchs</surname>, <given-names>E. C.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zivkovic A. R."><surname>Zivkovic</surname>, <given-names>A. R.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cunningham M. O."><surname>Cunningham</surname>, <given-names>M. O.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Middleton S."><surname>Middleton</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lebeau F. E."><surname>Lebeau</surname>, <given-names>F. E.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bannerman D. M."><surname>Bannerman</surname>, <given-names>D. M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rozov A."><surname>Rozov</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Whittington M. A."><surname>Whittington</surname>, <given-names>M. A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Traub R. D."><surname>Traub</surname>, <given-names>R. D.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rawlins J. N."><surname>Rawlins</surname>, <given-names>J. N.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Monyer H."><surname>Monyer</surname>, <given-names>H.</given-names></string-name> (<year>2007</year>) <article-title hwp:id="article-title-35">Recruitment of parvalbumin-positive interneurons determines hippocampal function and associated behavior</article-title>. <source hwp:id="source-34">Neuron</source> <volume>53</volume>, <fpage>591</fpage>–<lpage>604</lpage></citation></ref><ref id="c35" hwp:id="ref-35" hwp:rev-id="xref-ref-35-1"><label>35.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.35" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-35"><string-name name-style="western" hwp:sortable="Mann E. O."><surname>Mann</surname>, <given-names>E. O.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Radcliffe C. A."><surname>Radcliffe</surname>, <given-names>C. A.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Paulsen O."><surname>Paulsen</surname>, <given-names>O.</given-names></string-name> (<year>2005</year>) <article-title hwp:id="article-title-36">Hippocampal gamma-frequency oscillations: from interneurones to pyramidal cells, and back</article-title>. <source hwp:id="source-35">J Physiol</source> <volume>562</volume>, <fpage>55</fpage>–<lpage>63</lpage></citation></ref><ref id="c36" hwp:id="ref-36" hwp:rev-id="xref-ref-36-1"><label>36.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.36" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-36"><string-name name-style="western" hwp:sortable="Traub R. D."><surname>Traub</surname>, <given-names>R. D.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Whittington M. A."><surname>Whittington</surname>, <given-names>M. A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Colling S. B."><surname>Colling</surname>, <given-names>S. B.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Buzsaki G."><surname>Buzsaki</surname>, <given-names>G.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Jefferys J. G."><surname>Jefferys</surname>, <given-names>J. G.</given-names></string-name> (<year>1996</year>) <article-title hwp:id="article-title-37">Analysis of gamma rhythms in the rat hippocampus in vitro and in vivo</article-title>. <source hwp:id="source-36">J Physiol</source> <volume>493</volume> (<issue>Pt 2</issue>), <fpage>471</fpage>–<lpage>484</lpage></citation></ref><ref id="c37" hwp:id="ref-37" hwp:rev-id="xref-ref-37-1 xref-ref-37-2"><label>37.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.37" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-37"><string-name name-style="western" hwp:sortable="Homayoun H."><surname>Homayoun</surname>, <given-names>H.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Moghaddam B."><surname>Moghaddam</surname>, <given-names>B.</given-names></string-name> (<year>2007</year>) <article-title hwp:id="article-title-38">NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons</article-title>. <source hwp:id="source-37">J Neurosci</source> <volume>27</volume>, <fpage>11496</fpage>–<lpage>11500</lpage></citation></ref><ref id="c38" hwp:id="ref-38" hwp:rev-id="xref-ref-38-1"><label>38.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.38" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-38"><string-name name-style="western" hwp:sortable="Hakami T."><surname>Hakami</surname>, <given-names>T.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Jones N. C."><surname>Jones</surname>, <given-names>N. C.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tolmacheva E. A."><surname>Tolmacheva</surname>, <given-names>E. A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gaudias J."><surname>Gaudias</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chaumont J."><surname>Chaumont</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Salzberg M."><surname>Salzberg</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="O’Brien T. J."><surname>O’Brien</surname>, <given-names>T. J.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Pinault D."><surname>Pinault</surname>, <given-names>D.</given-names></string-name> (<year>2009</year>) <article-title hwp:id="article-title-39">NMDA receptor hypofunction leads to generalized and persistent aberrant gamma oscillations independent of hyperlocomotion and the state of consciousness</article-title>. <source hwp:id="source-38">PLoS One</source> <volume>4</volume>, <fpage>e6755</fpage></citation></ref><ref id="c39" hwp:id="ref-39" hwp:rev-id="xref-ref-39-1"><label>39.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.39" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-39"><string-name name-style="western" hwp:sortable="Benali A."><surname>Benali</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Trippe J."><surname>Trippe</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Weiler E."><surname>Weiler</surname>, <given-names>E.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mix A."><surname>Mix</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Petrasch-Parwez E."><surname>Petrasch-Parwez</surname>, <given-names>E.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Girzalsky W."><surname>Girzalsky</surname>, <given-names>W.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Eysel U. T."><surname>Eysel</surname>, <given-names>U. T.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Erdmann R."><surname>Erdmann</surname>, <given-names>R.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Funke K."><surname>Funke</surname>, <given-names>K.</given-names></string-name> (<year>2011</year>) <article-title hwp:id="article-title-40">Theta-burst transcranial magnetic stimulation alters cortical inhibition</article-title>. <source hwp:id="source-39">J Neurosci</source> <volume>31</volume>, <fpage>1193</fpage>–<lpage>1203</lpage></citation></ref><ref id="c40" hwp:id="ref-40" hwp:rev-id="xref-ref-40-1 xref-ref-40-2"><label>40.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.40" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-40"><string-name name-style="western" hwp:sortable="Sauer J. F."><surname>Sauer</surname>, <given-names>J. F.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Struber M."><surname>Struber</surname>, <given-names>M.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Bartos M."><surname>Bartos</surname>, <given-names>M.</given-names></string-name> (<year>2015</year>) <article-title hwp:id="article-title-41">Impaired fast-spiking interneuron function in a genetic mouse model of depression</article-title>. <source hwp:id="source-40">Elife</source> <volume>4</volume></citation></ref><ref id="c41" hwp:id="ref-41" hwp:rev-id="xref-ref-41-1"><label>41.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.41" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-41"><string-name name-style="western" hwp:sortable="Nagy V."><surname>Nagy</surname>, <given-names>V.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bozdagi O."><surname>Bozdagi</surname>, <given-names>O.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Huntley G. W."><surname>Huntley</surname>, <given-names>G. W.</given-names></string-name> (<year>2007</year>) <article-title hwp:id="article-title-42">The extracellular protease matrix metalloproteinase-9 is activated by inhibitory avoidance learning and required for long-term memory</article-title>. <source hwp:id="source-41">Learn Mem</source> <volume>14</volume>, <fpage>655</fpage>–<lpage>664</lpage></citation></ref><ref id="c42" hwp:id="ref-42" hwp:rev-id="xref-ref-42-1"><label>42.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.42" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-42"><string-name name-style="western" hwp:sortable="Foscarin S."><surname>Foscarin</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Raha-Chowdhury R."><surname>Raha-Chowdhury</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fawcett J. W."><surname>Fawcett</surname>, <given-names>J. W.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Kwok J. C. F."><surname>Kwok</surname>, <given-names>J. C. F.</given-names></string-name> (<year>2017</year>) <article-title hwp:id="article-title-43">Brain ageing changes proteoglycan sulfation, rendering perineuronal nets more inhibitory</article-title>. <source hwp:id="source-42">Aging (Albany NY)</source> <volume>9</volume>, <fpage>1607</fpage>–<lpage>1622</lpage></citation></ref><ref id="c43" hwp:id="ref-43" hwp:rev-id="xref-ref-43-1"><label>43.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.43" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-43"><string-name name-style="western" hwp:sortable="Carulli D."><surname>Carulli</surname>, <given-names>D.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pizzorusso T."><surname>Pizzorusso</surname>, <given-names>T.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kwok J. C."><surname>Kwok</surname>, <given-names>J. C.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Putignano E."><surname>Putignano</surname>, <given-names>E.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Poli A."><surname>Poli</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Forostyak S."><surname>Forostyak</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Andrews M. R."><surname>Andrews</surname>, <given-names>M. R.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Deepa S. S."><surname>Deepa</surname>, <given-names>S. S.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Glant T. T."><surname>Glant</surname>, <given-names>T. T.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Fawcett J. W."><surname>Fawcett</surname>, <given-names>J. W.</given-names></string-name> (<year>2010</year>) <article-title hwp:id="article-title-44">Animals lacking link protein have attenuated perineuronal nets and persistent plasticity</article-title>. <source hwp:id="source-43">Brain</source> <volume>133</volume>, <fpage>2331</fpage>–<lpage>2347</lpage></citation></ref><ref id="c44" hwp:id="ref-44" hwp:rev-id="xref-ref-44-1"><label>44.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.44" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-44"><string-name name-style="western" hwp:sortable="Zanasi M."><surname>Zanasi</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pecorella M."><surname>Pecorella</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chiaramonte C."><surname>Chiaramonte</surname>, <given-names>C.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Niolu C."><surname>Niolu</surname>, <given-names>C.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Siracusano A."><surname>Siracusano</surname>, <given-names>A.</given-names></string-name> (<year>2008</year>) <article-title hwp:id="article-title-45">Dreams by persons with mood disorders</article-title>. <source hwp:id="source-44">Psychol Rep</source> <volume>103</volume>, <fpage>381</fpage>–<lpage>394</lpage></citation></ref><ref id="c45" hwp:id="ref-45" hwp:rev-id="xref-ref-45-1"><label>45.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.45" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-45"><string-name name-style="western" hwp:sortable="Voss U."><surname>Voss</surname>, <given-names>U.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Holzmann R."><surname>Holzmann</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hobson A."><surname>Hobson</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Paulus W."><surname>Paulus</surname>, <given-names>W.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Koppehele-Gossel J."><surname>Koppehele-Gossel</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Klimke A."><surname>Klimke</surname>, <given-names>A.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Nitsche M. A."><surname>Nitsche</surname>, <given-names>M. A.</given-names></string-name> (<year>2014</year>) <article-title hwp:id="article-title-46">Induction of self awareness in dreams through frontal low current stimulation of gamma activity</article-title>. <source hwp:id="source-45">Nat Neurosci</source> <volume>17</volume>, <fpage>810</fpage>–<lpage>812</lpage></citation></ref><ref id="c46" hwp:id="ref-46" hwp:rev-id="xref-ref-46-1"><label>46.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.46" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-46"><string-name name-style="western" hwp:sortable="Tribl G. G."><surname>Tribl</surname>, <given-names>G. G.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wetter T. C."><surname>Wetter</surname>, <given-names>T. C.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Schredl M."><surname>Schredl</surname>, <given-names>M.</given-names></string-name> (<year>2013</year>) <article-title hwp:id="article-title-47">Dreaming under antidepressants: a systematic review on evidence in depressive patients and healthy volunteers</article-title>. <source hwp:id="source-46">Sleep Med Rev</source> <volume>17</volume>, <fpage>133</fpage>–<lpage>142</lpage></citation></ref><ref id="c47" hwp:id="ref-47" hwp:rev-id="xref-ref-47-1 xref-ref-47-2 xref-ref-47-3"><label>47.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.47" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-47"><string-name name-style="western" hwp:sortable="Mendez P."><surname>Mendez</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pazienti A."><surname>Pazienti</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Szabo G."><surname>Szabo</surname>, <given-names>G.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Bacci A."><surname>Bacci</surname>, <given-names>A.</given-names></string-name> (<year>2012</year>) <article-title hwp:id="article-title-48">Direct alteration of a specific inhibitory circuit of the hippocampus by antidepressants</article-title>. <source hwp:id="source-47">J Neurosci</source> <volume>32</volume>, <fpage>16616</fpage>–<lpage>16628</lpage></citation></ref><ref id="c48" hwp:id="ref-48"><label>48.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.48" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-48"><string-name name-style="western" hwp:sortable="Wojtowicz A. M."><surname>Wojtowicz</surname>, <given-names>A. M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="van den Boom L."><surname>van den Boom</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chakrabarty A."><surname>Chakrabarty</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Maggio N."><surname>Maggio</surname>, <given-names>N.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Haq R. U."><surname>Haq</surname>, <given-names>R. U.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Behrens C. J."><surname>Behrens</surname>, <given-names>C. J.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Heinemann U."><surname>Heinemann</surname>, <given-names>U.</given-names></string-name> (<year>2009</year>) <article-title hwp:id="article-title-49">Monoamines block kainate-and carbachol-induced gamma-oscillations but augment stimulus-induced gamma-oscillations in rat hippocampus in vitro</article-title>. <source hwp:id="source-48">Hippocampus</source> <volume>19</volume>, <fpage>273</fpage>–<lpage>288</lpage></citation></ref><ref id="c49" hwp:id="ref-49" hwp:rev-id="xref-ref-49-1"><label>49.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.49" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-49"><string-name name-style="western" hwp:sortable="Hajos M."><surname>Hajos</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hoffmann W. E."><surname>Hoffmann</surname>, <given-names>W. E.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Robinson D. D."><surname>Robinson</surname>, <given-names>D. D.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Yu J. H."><surname>Yu</surname>, <given-names>J. H.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Hajos-Korcsok E."><surname>Hajos-Korcsok</surname>, <given-names>E.</given-names></string-name> (<year>2003</year>) <article-title hwp:id="article-title-50">Norepinephrine but not serotonin reuptake inhibitors enhance theta and gamma activity of the septo-hippocampal system</article-title>. <source hwp:id="source-49">Neuropsychopharmacology</source> <volume>28</volume>, <fpage>857</fpage>–<lpage>864</lpage></citation></ref><ref id="c50" hwp:id="ref-50" hwp:rev-id="xref-ref-50-1"><label>50.</label><citation publication-type="journal" citation-type="journal" ref:id="432419v1.50" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-50"><string-name name-style="western" hwp:sortable="Janusz A."><surname>Janusz</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Milek J."><surname>Milek</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Perycz M."><surname>Perycz</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pacini L."><surname>Pacini</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bagni C."><surname>Bagni</surname>, <given-names>C.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kaczmarek L."><surname>Kaczmarek</surname>, <given-names>L.</given-names></string-name>, and <string-name name-style="western" hwp:sortable="Dziembowska M."><surname>Dziembowska</surname>, <given-names>M.</given-names></string-name> (<year>2013</year>) <article-title hwp:id="article-title-51">The Fragile X mental retardation protein regulates matrix metalloproteinase 9 mRNA at synapses</article-title>. <source hwp:id="source-50">J Neurosci</source> <volume>33</volume>, <fpage>18234</fpage>–<lpage>18241</lpage></citation></ref></ref-list></back></article>
